Feedback / Questions
AT-04 - Attralus
AT-07 - Attralus, Ossianix
https://www.globenewswire.com/news-release/2023/04/03/2639387/0/en/Attralus-Presents-New-Preclinical-Data-on-AT-04-and-AT-07-Pan-Amyloid-Removal-Therapeutics-Targeting-Neurodegenerative-Disorders-at-AD-PD-2023.html
Apr 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next